Nancy Stagliano Pandion Therapeutics, Inc. (PAND) insider trading activity
Nancy Stagliano is Director of Pandion Therapeutics, Inc.. Currently has a direct ownership of 0 shares of PAND, which is worth approximately $0. The most recent transaction as insider was on Apr 01, 2021, when has been sold 1,000 shares (Common Stock) at a price of $60.0 per share, resulting in proceeds of $60,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
        Shares Held (Direct Ownership)
        0
                  
          
      
      
    
                  
                    0%
                  
            3M change
          
                    
          
          
                
                  0%
                
             12M change
          
                    
        
        Total Value Held
          $0
      
      
    
        NS
    
    
    Nancy Stagliano
        Director
      
       
        
        Watertown, MA